|4Sep 2, 5:15 PM ET

Lavino Francesco Maria 4

4 · Nabriva Therapeutics plc · Filed Sep 2, 2020

Insider Transaction Report

Form 4
Period: 2020-08-31
Lavino Francesco Maria
Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-08-31$0.62/sh366$227185,759 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4